A decade of reporting from the frontiers of health and medicine. ## Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout. Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.. Plenty of news today, and also a deal that is running out soon: Buy one year of STAT+, get one year free. Vertex said yesterday it will spend $10 billion to acquire Crinetics Pharmaceuticals, a biotech developing drugs for rare endocrine disorders. To read the rest of this story subscribe to STAT+. Your morning rundown of the science, politics, and money driving biotech today. 2. ### STAT Plus: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk.
Top Match Report: Team X's Championship Journey
Quickly grasp key match information with 蜂鸟电竞's professional analysis, never missing a moment.
Read More
